A Review of Aflibercept Treatment for Macular Disease
Open Access
- 13 June 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Ophthalmology and Therapy
- Vol. 10 (3), 413-428
- https://doi.org/10.1007/s40123-021-00354-1
Abstract
Aflibercept is a fully human recombinant fusion protein that includes the second domain of human VEGF receptor 1 and the third domain of human VEGF receptor 2. Despite the important role played by VEGF in maintaining the physiological condition of the retina under normal conditions, dysregulation of VEGF can result in pathological alterations including hyperpermeability of the retinal capillaries and migration and proliferation of retinal endothelial cells. Over the years, a number of studies have evaluated the use of intravitreal aflibercept in different retinal diseases. In this review, we aim to summarize the scientific evidence and recommendations for use of intravitreal aflibercept in neovascular age-related macular degeneration, diabetic macular oedema, macular oedema associated with retinal vein occlusion, and myopic choroidal neovascularization.Keywords
This publication has 65 references indexed in Scilit:
- Safety of ranibizumab in routine clinical practice: 1-year retrospective pooled analysis of four European neovascular AMD registries within the LUMINOUS programmeBritish Journal of Ophthalmology, 2013
- Intravitreal Aflibercept Injection for Macular Edema Secondary to Central Retinal Vein Occlusion: 1-Year Results From the Phase 3 COPERNICUS StudyAmerican Journal of Ophthalmology, 2013
- VEGF Trap-Eye for macular oedema secondary to central retinal vein occlusion: 6-month results of the phase III GALILEO studyBritish Journal of Ophthalmology, 2013
- Vascular Endothelial Growth Factor Trap-Eye for Macular Edema Secondary to Central Retinal Vein Occlusion: Six-Month Results of the Phase 3 COPERNICUS StudyOphthalmology, 2012
- Natural History of Branch Retinal Vein Occlusion: An Evidence-Based Systematic ReviewOphthalmology, 2010
- Diabetic Retinopathy: Understanding Pathologic Angiogenesis and Exploring its Treatment Options~!2009-10-10~!2009-11-07~!2010-03-04~!The Open Circulation & Vascular Journal, 2010
- The Prevalence of Retinal Vein Occlusion: Pooled Data from Population Studies from the United States, Europe, Asia, and AustraliaOphthalmology, 2010
- The Natural History and Prognosis of Neovascular Age-Related Macular Degeneration: A Systematic Review of the Literature and Meta-analysisOphthalmology, 2008
- Basic understanding of current classification and management of retinoblastomaCurrent Opinion in Opthalmology, 2006
- The epidemiology of retinal vein occlusion: The Beaver Dam Eye Study. Klein R, Klein BEK, Moss SE, Meuer SM. Tr Am Ophth Soc 2000;98:133–143.American Journal of Ophthalmology, 2001